Deepti Telaraja

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, George Washington University

MedicineImmunology and MicrobiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma”.

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1272

N/A

1.4DataRank · unranked

35 citations

Yvette L. Kasamon, Justin S. Collazo, Ruby Leong, Kun Wang, P Li +8 more

Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles

Cytotherapy(2023)10.1016/j.jcyt.2023.03.014

N/A

0DataRank · unranked

7 citations

Palak Sekhri, Deepti Telaraja, Jie Chen, Samantha J. Chin, Katherine B. Chiappinelli +5 more